Further, based upon their observations of its preferential expression in classical and mesenchymal gliomas, rather than the neural and proneural subtypes, they advocated that HOTAIR could serve as a relevant biomarker for differentiating gliomas on the bases of the different gene expression-based molecular subtypes. The gene discussed is HOTAIR; the disease is central nervous system cancer.